UFC News & FeaturesUFC Heavyweight Alvin Hines Suspended 1 Year for Multiple Substances
The
Ultimate Fighting Championship appears to be sending a message
that they are still testing fighters on the regular.
According a combined statement from the UFC and Combat Sports Anti-Doping (CSAD) on Friday, heavyweight Alvin Hines has been suspended for a year due to multiple failed drug tests both in- and out-of-competition. Per CSAD, Hines was flagged for anabolic steroids of drostanolone and its related metabolites, as well as tamoxifen—a breast cancer treatment drug also used to slow or block the release of estrogen.
These substances all together were in his system the first time he
was tested in June, and subsequent tests in July also showed the
same results. Hines claimed he took these banned substances prior
to his joining the UFC, but he could have avoided as lengthy a
sentence had he disclosed taking them prior to his promotional
debut on June 28. “Goozie” lost a decision to Jhonata
Diniz that night, and his suspension took effect on July 11
based on the first date of his suspension. The Nevada State
Athletic Commission also has the option to pass down their own
sentence, and he is currently awaiting a hearing on an unannounced
date.
Per CSAD, Hines was entirely cooperative during the investigative process. “Goozie” informed CSAD—after the fact—which substances he consumed and when. He also sat for a lengthy interview to go over his case, and stated that his expectation was that the banned products would be out of his system come fight night. As a result, what could have been a two-year suspension was reduced to one, and he will be allowed to compete in the Octagon again on July 11, 2026—if the promotion does not release him outright before then.
”Combat Sports Anti-Doping (CSAD) announced today that Alvin Hines, of Deer River, Minnesota, has accepted a 1-year period of ineligibility for a violation of the UFC Anti-Doping Policy (UFC ADP).
“Hines tested positive for the presence of the anabolic steroids Drostanolone, its metabolite, 3a-Hydroxy-2a-methyl-5a-androstan-17-one and testosterone metabolites, as well as a metabolite of Tamoxifen, 3-Hydroxy-4-methooxytamoxifen, a hormone and metabolic modulator. All of these substances are prohibited at all times under the UFC Anti-Doping Program and were present in samples collected out-of-competition from Hines on June 20, 2025, in Superior, Minnesota, in-competition on June 28, 2025, in Las Vegas, Nevada, and out-of-competition on July 5, 2025, in Grand Rapids, Minnesota. The evidence in this case reflected that Hines consumed these substances BEFORE he was signed to the UFC, however, he knowingly failed to disclose their use when his onboarding into the UFC Anti-Doping Program was completed on June 16, 2025.
“Notwithstanding the above facts in this case, Hines fully cooperated with CSAD’s investigation, including submitting to a detailed interview and providing CSAD with explicit details of his use of the above substances prior to joining the UFC, including his belief that these substances would no longer be present in his system when he signed with the UFC and was tested.
“Under the UFC ADP, CSAD evaluates each case and can reduce periods of ineligibility based on the athlete’s degree of fault and their level of cooperation. While Hines failed to disclose his prior use of these substances during onboarding, the estimated concentrations of these substances in Hines’ samples were reflective that they were near the tail end of excretion and supported his explanation of their use prior to being signed to the UFC and entering the UFC registered testing pool.
“Hines’ 1-year suspension began on July 11, 2025, the date on which he was placed under a provisional suspension. Additionally, the Nevada State Athletic Commission, who regulated Hines’ fight on June 28, 2025, where he tested positive in-competition, also retains jurisdiction over this matter and will separately adjudicate Hines’ adverse findings.”
According a combined statement from the UFC and Combat Sports Anti-Doping (CSAD) on Friday, heavyweight Alvin Hines has been suspended for a year due to multiple failed drug tests both in- and out-of-competition. Per CSAD, Hines was flagged for anabolic steroids of drostanolone and its related metabolites, as well as tamoxifen—a breast cancer treatment drug also used to slow or block the release of estrogen.
Advertisement
Cooperation From UFC Newcomer Led to Lesser Punishment
Per CSAD, Hines was entirely cooperative during the investigative process. “Goozie” informed CSAD—after the fact—which substances he consumed and when. He also sat for a lengthy interview to go over his case, and stated that his expectation was that the banned products would be out of his system come fight night. As a result, what could have been a two-year suspension was reduced to one, and he will be allowed to compete in the Octagon again on July 11, 2026—if the promotion does not release him outright before then.
The CSAD statement in its entirety reads as follows:
”Combat Sports Anti-Doping (CSAD) announced today that Alvin Hines, of Deer River, Minnesota, has accepted a 1-year period of ineligibility for a violation of the UFC Anti-Doping Policy (UFC ADP).
“Hines tested positive for the presence of the anabolic steroids Drostanolone, its metabolite, 3a-Hydroxy-2a-methyl-5a-androstan-17-one and testosterone metabolites, as well as a metabolite of Tamoxifen, 3-Hydroxy-4-methooxytamoxifen, a hormone and metabolic modulator. All of these substances are prohibited at all times under the UFC Anti-Doping Program and were present in samples collected out-of-competition from Hines on June 20, 2025, in Superior, Minnesota, in-competition on June 28, 2025, in Las Vegas, Nevada, and out-of-competition on July 5, 2025, in Grand Rapids, Minnesota. The evidence in this case reflected that Hines consumed these substances BEFORE he was signed to the UFC, however, he knowingly failed to disclose their use when his onboarding into the UFC Anti-Doping Program was completed on June 16, 2025.
“Notwithstanding the above facts in this case, Hines fully cooperated with CSAD’s investigation, including submitting to a detailed interview and providing CSAD with explicit details of his use of the above substances prior to joining the UFC, including his belief that these substances would no longer be present in his system when he signed with the UFC and was tested.
“Under the UFC ADP, CSAD evaluates each case and can reduce periods of ineligibility based on the athlete’s degree of fault and their level of cooperation. While Hines failed to disclose his prior use of these substances during onboarding, the estimated concentrations of these substances in Hines’ samples were reflective that they were near the tail end of excretion and supported his explanation of their use prior to being signed to the UFC and entering the UFC registered testing pool.
“Hines’ 1-year suspension began on July 11, 2025, the date on which he was placed under a provisional suspension. Additionally, the Nevada State Athletic Commission, who regulated Hines’ fight on June 28, 2025, where he tested positive in-competition, also retains jurisdiction over this matter and will separately adjudicate Hines’ adverse findings.”
UFC heavyweight Alvin Hines suspended 1 year after testing positive for the anabolic steroids Drostanolone ... testosterone metabolites and a metabolite of Tamoxifen, 3-Hydroxy-4-methooxytamoxifen#UFC pic.twitter.com/h6iMNKaEEz
— Damon Martin (@DamonMartin) August 15, 2025
« Previous Four-Pound Weight Miss for Bryan Battle Results in UFC 319 Bout Cancellation
Next UFC Signs Former Oktagon MMA Two-Division Champion »
More
